151 related articles for article (PubMed ID: 36612204)
1. CD3
Karjula T; Elomaa H; Niskakangas A; Mustonen O; Puro I; Kuopio T; Ahtiainen M; Mecklin JP; Seppälä TT; Wirta EV; Sihvo E; Väyrynen JP; Yannopoulos F; Helminen O
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612204
[TBL] [Abstract][Full Text] [Related]
2. Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases.
Ahtiainen M; Elomaa H; Väyrynen JP; Wirta EV; Kuopio T; Helminen O; Seppälä TT; Kellokumpu I; Mecklin JP
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810354
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance.
Xin H; Zhou C; Wang G; Liu Y; Zhang J; Liu Y; Li B; Zhang J; Su M; Li Z; Wang G
Heliyon; 2023 Feb; 9(2):e13048. PubMed ID: 36814622
[TBL] [Abstract][Full Text] [Related]
4. Tertiary lymphoid structures in pulmonary metastases of microsatellite stable colorectal cancer.
Karjula T; Niskakangas A; Mustonen O; Puro I; Elomaa H; Ahtiainen M; Kuopio T; Mecklin JP; Seppälä TT; Wirta EV; Sihvo E; Yannopoulos F; Helminen O; Väyrynen JP
Virchows Arch; 2023 Jul; 483(1):21-32. PubMed ID: 37337034
[TBL] [Abstract][Full Text] [Related]
5. Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.
Jary M; Liu WW; Yan D; Bai I; Muranyi A; Colle E; Brocheriou I; Turpin A; Radosevic-Robin N; Bourgoin P; Penault-Llorca F; Cohen R; Vernerey D; André T; Borg C; Shanmugam K; Svrcek M
Mol Oncol; 2022 Jun; 16(11):2260-2273. PubMed ID: 34954864
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.
Droeser RA; Hirt C; Viehl CT; Frey DM; Nebiker C; Huber X; Zlobec I; Eppenberger-Castori S; Tzankov A; Rosso R; Zuber M; Muraro MG; Amicarella F; Cremonesi E; Heberer M; Iezzi G; Lugli A; Terracciano L; Sconocchia G; Oertli D; Spagnoli GC; Tornillo L
Eur J Cancer; 2013 Jun; 49(9):2233-42. PubMed ID: 23478000
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Immune Environment Analysis in Small Bowel Adenocarcinomas with Verified Mutational Landscape and Predisposing Conditions.
Wirta EV; Szeto S; Hänninen U; Ahtiainen M; Böhm J; Mecklin JP; Aaltonen LA; Seppälä TT
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32718028
[No Abstract] [Full Text] [Related]
8. Loss of survival advantage for deficient mismatch repair in patients with advanced colorectal cancer may be caused by changes in prognostic value of CD8+T cell.
Wang B; Li F; Guo L; Lu S; Ma J; Ma Y; Meng Y; Wang J; Zhou X; Fu W
World J Surg Oncol; 2020 Aug; 18(1):196. PubMed ID: 32767974
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
[TBL] [Abstract][Full Text] [Related]
10. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.
Kikuchi T; Mimura K; Okayama H; Nakayama Y; Saito K; Yamada L; Endo E; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Kono K
Oncol Lett; 2019 Dec; 18(6):5977-5985. PubMed ID: 31788072
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral Cytotoxic T-Lymphocyte Density and PD-L1 Expression Are Prognostic Biomarkers for Patients with Colorectal Cancer.
Calik I; Calik M; Turken G; Ozercan IH; Dagli AF; Artas G; Sarikaya B
Medicina (Kaunas); 2019 Oct; 55(11):. PubMed ID: 31683723
[No Abstract] [Full Text] [Related]
12. Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma.
Noh BJ; Kwak JY; Eom DW
BMC Cancer; 2020 Jan; 20(1):58. PubMed ID: 31992245
[TBL] [Abstract][Full Text] [Related]
13. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
14. New Artificial Intelligence Score and Immune Infiltrates as Prognostic Factors in Colorectal Cancer With Brain Metastases.
Randrian V; Desette A; Emambux S; Derangere V; Roussille P; Frouin E; Godet J; Karayan-Tapon L; Ghiringhelli F; Tougeron D
Front Immunol; 2021; 12():750407. PubMed ID: 34733283
[TBL] [Abstract][Full Text] [Related]
15. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
[TBL] [Abstract][Full Text] [Related]
16. Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases.
Berghoff AS; Ricken G; Widhalm G; Rajky O; Dieckmann K; Birner P; Bartsch R; Höller C; Preusser M
Histopathology; 2015 Jan; 66(2):289-99. PubMed ID: 25314639
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
18. Tumour-Infiltrating Lymphocytes (TILs) and PD-L1 Expression Correlate with Lymph Node Metastasis, High-Grade Transformation and Shorter Metastasis-Free Survival in Patients with Acinic Cell Carcinoma (AciCC) of the Salivary Glands.
Hiss S; Eckstein M; Segschneider P; Mantsopoulos K; Iro H; Hartmann A; Agaimy A; Haller F; Mueller SK
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33669038
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotype based on inflammatory cells, PD-1/PD-L1 signalling pathway and M2 macrophages predicts survival in gastric cancer.
Junttila A; Helminen O; Väyrynen JP; Ahtiainen M; Kenessey I; Jalkanen S; Mecklin JP; Kellokumpu I; Kuopio T; Böhm J; Mrena J
Br J Cancer; 2020 Nov; 123(11):1625-1632. PubMed ID: 32943749
[TBL] [Abstract][Full Text] [Related]
20. Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis.
Berntsson J; Eberhard J; Nodin B; Leandersson K; Larsson AH; Jirström K
Oncoimmunology; 2018; 7(8):e1465165. PubMed ID: 30221062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
